I. Roger

发表

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms

J. Cortijo, P. Montero, J. Milara, 2021, International journal of molecular sciences.

Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients

J. Pérez-Fidalgo, A. Cervantes, J. Cortijo, 2022, Cancers.

Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model

J. Cortijo, P. Montero, J. Milara, 2022, International journal of molecular sciences.

Senescence Alterations in Pulmonary Hypertension

J. Cortijo, J. Milara, Inés Roger, 2021, Cells.

MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease

J. Cortijo, P. Montero, J. Milara, 2018, Respiratory Research.

The JAK2 pathway is activated in idiopathic pulmonary fibrosis

J. Escrivá, M. Molina-Molina, J. Cortijo, 2018, Respiratory Research.

Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?

J. Signes-Costa, P. Montero, Inés Roger, 2022, Biomedicines.

Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview

J. Cortijo, P. Montero, J. Milara, 2023, Cancers.

Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro

J. Pérez-Fidalgo, J. Cortijo, P. Montero, 2022, Pharmaceuticals.

N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro

J. Cortijo, P. Montero, J. Milara, 2022, International journal of molecular sciences.

The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension

J. Cortijo, P. Montero, J. Milara, 2021, International journal of molecular sciences.

IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis

J. Escrivá, J. Cortijo, P. Montero, 2022, Respiratory Research.

Role of IL-11 in vascular function of pulmonary fibrosis patients

J. Cortijo, J. Milara, Beatriz Ballester, 2019, Pulmonary hypertension.

Influence of dose and exposition time in the effectiveness of N-Acetyl-l-cysteine treatment in A549 human epithelial cells

J. Cortijo, P. Montero, J. Milara, 2023, Heliyon.

Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies

J. Cortijo, P. Montero, J. Milara, 2022, International journal of molecular sciences.

Pharmacological characterization of a novel peptide inhibitor of the Keap1-Nrf2 protein-protein interaction.

Miriam Góngora-Benítez, F. Albericio, J. Cortijo, 2022, Biochemical pharmacology.

Mechanisms underlying corticosteroid resistance in patients with asthma: a review of current knowledge

J. Cortijo, P. Montero, J. Milara, 2023, Expert review of respiratory medicine.

Targeting IL‐11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension‐associated lung fibrosis

J. Escrivá, J. Cortijo, P. Montero, 2024, British journal of pharmacology.

Targeting IL-11 system as a treatment of pulmonary arterial hypertension.

J. Escrivá, J. Cortijo, P. Montero, 2023, Pharmacological research.

Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11.

J. Cortijo, P. Montero, J. Milara, 2024, European journal of pharmacology.

Phosphodiesterase 4 is overexpressed in keloid epidermal scars and its inhibition reduces keratinocyte fibrotic alterations

P. Montero, J. Milara, Pilar Ribera, 2024, Molecular medicine.

Damaging effects of UVA, blue light, and infrared radiation: in vitro assessment on a reconstructed full-thickness human skin

J. Cortijo, P. Montero, J. Milara, 2023, Frontiers in medicine.